This could be explained by our selection of the CD81-expressing EV population, which was increased and thus detectable in cancer patients’ CD81sEV, or by the higher levels of these two FAs in the CD81sEV, as shown in the sera of colorectal cancer patients [68]. Here, CD81 is linked to cancer.